Medistim ASA
MEDI
Rank in Stocks
#10984
Medistim ASA develops, produces, services, leases, and distributes medical... Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Share Price
$33.93
Last synced: 2026-11-09
Market Cap
$620.29M
Change (1 day)
4.90%
Change (1 year)
37.89%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Medistim ASA (MEDI)
Category
Healthcare
Operating Margin for Medistim ASA (MEDI)
Operating Margin as of November 2026 TTM: 28.62%
According to Medistim ASA's latest financial reports, its current operating margin (TTM) is 28.62%. At the end of 2025 the company had an operating margin of 28.04%.
Operating Margin history for Medistim ASA from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 28.62% | 2.07% |
| 2025 | 28.04% | 20.34% |
| 2024 | 23.30% | -7.61% |
| 2023 | 25.22% | -13.18% |
| 2022 | 29.05% | 4.38% |
| 2021 | 27.83% | 3.80% |
| 2020 | 26.81% | 6.60% |
| 2019 | 25.15% | 9.83% |
| 2018 | 22.90% | 3.57% |
| 2017 | 22.11% | 3.08% |
| 2016 | 21.45% | 6.66% |
| 2015 | 20.11% | -0.64% |
| 2014 | 20.24% | 8.18% |
| 2013 | 18.71% | -17.21% |
| 2012 | 22.60% | 51.17% |
| 2011 | 14.95% | -3.17% |
| 2010 | 15.44% | -15.07% |
| 2009 | 18.18% | 4.72% |
| 2008 | 17.36% | 10.15% |
| 2007 | 15.76% | -84.03% |
| 2006 | 98.69% | 0.25% |
| 2005 | 98.44% | -0.43% |
| 2004 | 98.87% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -99.47% |
US
|
|
| 18.08% | -99.37% |
IE
|
|
| 21.25% | -99.26% |
US
|
|
| 21.05% | -99.26% |
US
|
|
| 28.09% | -99.02% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Medistim ASA's operating margin
What is Medistim ASA's operating margin?
Medistim ASA's operating margin is 28.62%, as of Nov 2026.
What was Medistim ASA's operating margin in 2025?
In 2025, Medistim ASA's operating margin was 28.04%, compared with 23.30% in 2024.
How has Medistim ASA's operating margin changed since 2020?
From 2020 to 2025, Medistim ASA's operating margin was highest in 2022 (29.05%) and lowest in 2024 (23.30%).
How does Medistim ASA's operating margin compare with similar companies?
Medistim ASA's operating margin (28.62%) is higher than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.